| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.6 |